Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple‐negative breast cancer

16 Jun 2020

Abstract excerpt

Triple-negative breast cancer (TNBC) is a highly heterogeneous disease. The aim of this study is to identify the diagnostic and poor prognostic signatures in TNBC by exploring the aberrant DNA methylation and gene expression. Differential expression and methylation analysis of the TNBC and paracancer samples from The Cancer Genome Atlas were performed. Gene set enrichment and protein-protein interaction (PPI)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32544280
DOI: 10.1002/cbin.11406

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple‐negative breast cancerPMID 32544280Read ↗

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read ↗

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancerSemantic proximity Read ↗

In silico analysis of differentially expressed-aberrantly methylated genes in breast cancer for prognostic and therapeutic targetsSemantic proximity Read ↗

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkersSemantic proximity Read ↗

Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity Read ↗

Machine learning analysis identifies genes differentiating triple negative breast cancersSemantic proximity Read ↗

Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray AnalysisSemantic proximity Read ↗

Molecular subtypes and precision treatment of triple-negative breast cancerSemantic proximity Read ↗

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity Read ↗

In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkersSemantic proximity Read ↗

Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.